Primex Pharmaceuticals Appoints Alan Knox as Head of Global Marketing
1.6.2016 07:00 | Business Wire
Swiss pharmaceutical company Primex Pharmaceuticals AG announces the appointment of Alan Knox as Head of Global Marketing. On July 1, 2016, he joins Primex Pharmaceuticals’ Executive Management Team.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160601005092/en/
Alan Knox (Photo: Business Wire)
Most recently, Alan Knox worked for MSD International AG as VP Global Marketing. At MSD, he has also held responsibilities for Global Portfolio Strategy and Regional Operations in EU/EEMEA. Prior to joining MSD, he held line management roles in Sandoz and AstraZeneca.
Mr. Knox will be in charge of the global go-to-market strategy for a novel solution for pediatric anesthesiology, recently acquired from Advicenne. He has previous experience with the launch of Diprivan (propofol) in the UK and emerging markets.
In February 2016, Primex Pharmaceuticals acquired the global rights for an advanced oral pharmaceutical candidate for pediatric anesthesiology. With this acquisition, Primex Pharmaceuticals expanded its portfolio with a unique product whose market potential is evaluated as hundreds of millions of euros.
Panu Paappanen, Chairman of the Board and Owner, commented: “2016 could mark a milestone for Primex Pharmaceuticals. By strengthening our organization, we secure the in-house expertise needed to realize the full potential of our acquisition and build our anesthesia pipeline.”
Kari Sarvanto, President and Co-Founder of Primex Group, added: “I am excited to welcome a highly experienced colleague to our team to bring the new, patient-friendly solution to the market. We are committed to making Primex Pharmaceuticals the leading global anesthesia pharmaceutical company.”
About Primex Pharmaceuticals
Primex Pharmaceuticals is a fast growing global specialty company spearheading a new lean pharmaceutical business model.
Primex aims to become the leading global innovative Anesthesia company helping patients undergo a wide range of medical procedures. With a portfolio of strong, trusted anesthesia products including Recofol N (propofol) acquired from Bayer, and the recent acquisition of a novel, oral solution pharmaceutical candidate for pediatric anesthesiology from Advicenne, Primex Pharmaceuticals will continue to identify and acquire new medications that complete the ‘Triad of Anesthesia’.
Primex Pharmaceuticals' global partner network operates in over 40 countries and reaches a population of one billion. The company is headquartered in Zug, Switzerland; all Primex products are manufactured in the EU. Primex Pharmaceuticals has proven underlying business operations and historically strong revenue growth.
More at www.Primexpharma.com
Mr Kari Sarvanto, President
Mobile: +41 796 162 694
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Keio Plaza Hotel Tokyo Starts "Ikebana" Flower Arrangement Workshops16.8.2017 14:00 | Pressemelding
Keio Plaza Hotel Tokyo, one of Japan’s most prestigious international hotels located in Shinjuku, Tokyo, starts special 45 minute classes to teach overseas guests about “Ikebana” flower arrangement which will be held on every other Thursday beginning from August in a private room for JPY3,000 per participant. Instruction and commentary will be provided by the renowned flower arrangement artist Hiroki Maeno. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005431/en/ From August, 2017, Keio Plaza Hotel Tokyo starts special 45 minute classes to teach overseas guests about "Ikebana" flower arrangement workshops. (Photo: Business Wire) Flower arrangement artist Hiroki Maeno has created special and unique flower arrangements for display in the main lobby of our hotel with each cha
Maxion Wheels to Feature Market Leading Commercial Vehicle Steel Wheels at COMTRANS 201716.8.2017 13:00 | Pressemelding
Maxion Wheels, the world’s largest wheel manufacturer, announced today its participation in the biennial COMTRANS / 17 International Commercial Vehicle Show held in Moscow, Russia from September 4 – 9, 2017, in Hall 15/ Stand 15-432. Customers and visitors to the Maxion Wheels exhibit will have the opportunity to learn more about the state-of-the-art commercial vehicle steel wheels that have supported the success of global original equipment manufacturers for almost 100 years. One of the key products on display will be the new 8.5” x 24” wheel for tubeless tire applications in Russia, the Middle East and Africa. The wheel boasts 15 percent less weight than the prior generation wheel, enhancing tire life and improving fuel efficiency. ABOUT MAXION WHEELS Maxion Wheels, a division of IOCHPE-MAXION S.A., is a leading wheel manufacturer for passenger cars,
Out-of-this-World Science Project to be Featured as Keynote at SC17’s High Performance Computing Conference in Denver16.8.2017 13:00 | Pressemelding
Professor Philip Diamond, Director General of the international Square Kilometer Array (SKA) project, will be the keynote speaker at SC17, the International Conference for High Performance Computing, Networking, Storage and Analysis in Denver, Nov. 12-17. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005129/en/ SC17 Keynote Speaker Philip Diamond (Photo: Business Wire) SKA is an international collaboration to build the world’s largest radio telescope that will change our understanding of space as we know it. Professor Diamond, accompanied by Dr. Rosie Bolton, SKA Regional Centre Project Scientist, will take SC17 attendees around the globe and out into the deepest reaches of the observable universe as they describe the SKA’s international partnership that will map and study the e
Scientist.com Ranks No. 155 on the 2017 Inc. 5000 List of Fastest-Growing Companies16.8.2017 12:06 | Pressemelding
Scientist.com, the leading marketplace for outsourced scientific services, today announced that it ranked no. 155 on Inc. magazine’s 2017 List of the 5000 Fastest-Growing privately-owned companies in America, and it ranked no. 11 in the country in the Health category. The San Diego-based company builds private marketplaces that connect many of the world’s largest life science research organizations with a global network of thousands of research suppliers. “Using Scientist.com, research organizations of pharmaceutical companies, biotech start-ups and academic and research institutes can get near instant access to thousands of the latest research technologies and services,” stated Paul A. Stone, JD, Partner at 5AM Ventures, a Scientist.com investor. “The marketplace saves researchers time, reduces costs, promotes access to innovation and ensures regulatory compliance. Scientist.com is im
CMB Successfully Goes-Live on Murex’s MX.3 Platform16.8.2017 08:00 | Pressemelding
Murex, a global leader in trading, risk management and processing solutions, is pleased to announce the successful launch of the MX.3 platform at China Merchants Bank (CMB). As one of China’s largest commercial banks, CMB financial market department currently averages 8,000 trades per day with a portfolio of 320,000 live trades on MX.3. CMB decided to launch the project to implement an enterprise-wide solution for their capital markets teams based in Shenzhen and Shanghai. This was done in order to improve control over their end-to-end trading cycle from front-to-back through risk, streamline and automate their operations, and enable new business. Murex’s MX.3 platform was selected as it provided the functional, geographical and product coverage that was required by the bank. Covering Front Office, Processing, Finance, and Risk Management, MX.3 also provides VaR analytics across all asset
euNetworks Adds New High Density Fibre Network in Manchester16.8.2017 08:00 | Pressemelding
euNetworks, a provider of bandwidth services in Europe, today announced it has made further investment in Manchester in the United Kingdom, having built out a new high density fibre network covering over 40 route kilometres in the city. This follows initial expansion into Manchester’s MediaCityUK in May 2016, which supported euNetworks’ Media customer’s bandwidth needs, as well as enabling a seamless network experience from London through to Manchester and Dublin and onwards to Europe. This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170816005067/en/ euNetworks Fibre in Manchester (Photo: Business Wire) This new network in Manchester city was designed for resilience, with fully diverse nodes. euNetworks undertook a combination of new construction and duct acquisition to complete this network
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom